OTCMKTS:CPMV Mosaic ImmunoEngineering (CPMV) Stock Price, News & Analysis $0.09 +0.01 (+11.97%) As of 11/20/2026 02:03 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsSEC Filings About Mosaic ImmunoEngineering Stock (OTCMKTS:CPMV) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get CPMV alerts:Sign Up Key Stats Today's Range$0.08▼$0.0950-Day Range$0.06▼$0.3352-Week Range$0.05▼$0.75Volume12,041 shsAverage Volume167 shsMarket Capitalization$616.12 thousandP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Mosaic ImmunoEngineering is a biotechnology company focused on developing immunotherapies for cancer. Its research centers on cowpea mosaic virus (CPMV), a plant virus being investigated as a way to stimulate immune responses against tumors. The company’s approach involves using CPMV particles as an investigational, locally administered treatment intended to activate the body’s immune system in and around tumors. Mosaic’s work is centered on developing this technology for potential use against solid tumors; it is not an approved cancer treatment.AI Generated. May Contain Errors. Read More Mosaic ImmunoEngineering Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks15th Percentile Overall ScoreCPMV MarketRank™: 0.7649122807 of 5 starsMosaic ImmunoEngineering scored higher than 15% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Mosaic ImmunoEngineering. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Mosaic ImmunoEngineering is -0.95, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Mosaic ImmunoEngineering is -0.95, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.04% of the float of Mosaic ImmunoEngineering has been sold short.Short Interest Ratio / Days to CoverMosaic ImmunoEngineering has a short interest ratio ("days to cover") of 0.16, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Mosaic ImmunoEngineering has recently increased by 330.58%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldMosaic ImmunoEngineering does not currently pay a dividend.Dividend GrowthMosaic ImmunoEngineering does not have a long track record of dividend growth. News and Social Media3.4 / 5News SentimentN/A News SentimentMosaic ImmunoEngineering has a news sentiment score of 1.38. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.41 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 1 news article for Mosaic ImmunoEngineering this week, compared to 0 articles on an average week. Company Ownership0.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Mosaic ImmunoEngineering insiders have not sold or bought any company stock.Percentage Held by Insiders80.99% of the stock of Mosaic ImmunoEngineering is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsMosaic ImmunoEngineering has minimal institutional ownership at this time.Read more about Mosaic ImmunoEngineering's insider trading history. Receive CPMV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Mosaic ImmunoEngineering and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CPMV Stock News HeadlinesMosaic ImmunoEngineering Inc. (OTCMKTS:CPMV) Shares Shorted: Short Interest Up 330.6% in OctoberNovember 12, 2026 | americanbankingnews.comMosaic ImmunoEngineering Delays Annual 10-K FilingJuly 12, 2026 | theglobeandmail.comELON + YOU + DECEMBER 8THElon Musk's next big project may be the most ambitious move of his career, and all signs point to December 8th. A free Masterclass claims to reveal what Musk filed with regulators and why he's working to keep it quiet. | Paradigm Press (Ad)Mosaic ImmunoEngineering, Inc. (CPMV) - Yahoo FinanceJune 27, 2025 | au.finance.yahoo.comMosaic ImmunoEngineering, Inc. (CPMV)November 17, 2024 | finance.yahoo.comMosaic Co.November 5, 2024 | wsj.comMosaic ImmunoEngineering (OTC:CPMV) Stock Quotes, Forecast and News SummaryOctober 7, 2024 | benzinga.comOlney: Roman villa mosaic found under Aldi supermarket siteDecember 20, 2023 | bbc.comBSee More Headlines CPMV Stock Analysis - Frequently Asked Questions How have CPMV shares performed this year? Mosaic ImmunoEngineering's stock was trading at $0.3110 on January 1st, 2026. Since then, CPMV shares have decreased by 72.6% and is now trading at $0.0851. How were Mosaic ImmunoEngineering's earnings last quarter? Mosaic ImmunoEngineering Inc. (OTCMKTS:CPMV) released its quarterly earnings data on Friday, November, 20th. The company reported ($0.02) earnings per share (EPS) for the quarter. How do I buy shares of Mosaic ImmunoEngineering? Shares of CPMV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings11/20/2026Today11/21/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolOTCMKTS:CPMV CIK836564 Webmosaicie.com Phone(657) 208-0890Fax760-547-2705Employees3Year FoundedN/AProfitability EPS (Trailing Twelve Months)($0.09) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$690 thousand Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-3,108.08% Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($1.03) per share Price / Book-0.08Miscellaneous Outstanding Shares7,240,000Free Float1,377,000Market Cap$616.12 thousand OptionableNot Optionable Beta-0.87 7 Stocks That Could Be Bigger Than Tesla, NVIDIA, and GoogleCould the next Tesla, NVIDIA, and Google be hiding in plain sight? Discover seven growth stocks with the potential to become tomorrow's market giants, fueled by breakthroughs in AI, nuclear energy, cybersecurity, and more.Get This Free Report This page (OTCMKTS:CPMV) was last updated on 11/20/2026 by MarketBeat.com Staff. From Our PartnersYour $7 scanner is waitingThe Instant Scanner is $7 in Bill Poulos's Black Friday sale. Every night it delivers a list showing which sto...Profits Run | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredELON + YOU + DECEMBER 8THElon Musk's next big project may be the most ambitious move of his career, and all signs point to December 8th...Paradigm Press | SponsoredCFA: Bank of America Said THISOn January 24th, 2022, Bank of America told Bloomberg something that should terrify every American with a savi...Decentralized Masters | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | Sponsored“IMPERIUM”: The #1 investment of 2027Could a strange new bio-chip be the most transformative innovation in history? Elon Musk calls it "amazing." A...Banyan Hill Publishing | SponsoredNoah’s Ark found?Scientists may have discovered Noah's Ark buried under a mountain in eastern Turkey, just two miles from the I...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mosaic ImmunoEngineering Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mosaic ImmunoEngineering With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.